BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1296567)

  • 21. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.
    Caron H; van Sluis P; van Hoeve M; de Kraker J; Bras J; Slater R; Mannens M; Voûte PA; Westerveld A; Versteeg R
    Nat Genet; 1993 Jun; 4(2):187-90. PubMed ID: 8102298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization of the 17q breakpoint of a constitutional 1;17 translocation in a patient with neuroblastoma within a 25-kb segment located between the ACCN1 and TLK2 genes and near the distal breakpoints of two microdeletions in neurofibromatosis type 1 patients.
    Van Roy N; Vandesompele J; Berx G; Staes K; Van Gele M; De Smet E; De Paepe A; Laureys G; van der Drift P; Versteeg R; Van Roy F; Speleman F
    Genes Chromosomes Cancer; 2002 Oct; 35(2):113-20. PubMed ID: 12203774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues.
    Reale MA; Hu G; Zafar AI; Getzenberg RH; Levine SM; Fearon ER
    Cancer Res; 1994 Aug; 54(16):4493-501. PubMed ID: 8044801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The involvement of oncogenes and suppressor genes in human neoplasia.
    Brodeur GM
    Adv Pediatr; 1987; 34():1-44. PubMed ID: 3318293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translocations and rearrangements involving chromosome 21.
    Patterson D; Schild D; Lai LW
    Prog Clin Biol Res; 1990; 360():27-37. PubMed ID: 2247509
    [No Abstract]   [Full Text] [Related]  

  • 27. Cytogenetics and molecular genetics of nervous system tumors.
    Rey JA; Pestaña A; Bello MJ
    Oncol Res; 1992; 4(8-9):321-31. PubMed ID: 1336685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variety and complexity of chromosome 17 translocations in neuroblastoma.
    Schleiermacher G; Raynal V; Janoueix-Lerosey I; Combaret V; Aurias A; Delattre O
    Genes Chromosomes Cancer; 2004 Feb; 39(2):143-50. PubMed ID: 14695994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of the LGI and SLIT families of genes in human cancer cells.
    Rossi MR; Huntoon K; Cowell JK
    Gene; 2005 Aug; 356():85-90. PubMed ID: 16000246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stepwise occurrence of a complex unbalanced translocation in neuroblastoma leading to insertion of a telomere sequence and late chromosome 17q gain.
    Schleiermacher G; Bourdeaut F; Combaret V; Picrron G; Raynal V; Aurias A; Ribeiro A; Janoueix-Lerosey I; Delattre O
    Oncogene; 2005 May; 24(20):3377-84. PubMed ID: 15735707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evolution of clinical molecular genetics. Neuroblastoma as a model tumor.
    Israel MA
    Am J Pediatr Hematol Oncol; 1986; 8(2):163-72. PubMed ID: 3526938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogene probes in the detection of human cancer.
    Showe LC; Croce CM
    Clin Physiol Biochem; 1987; 5(3-4):227-37. PubMed ID: 3621798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparable transforming capacities and differential gene expression patterns of variant FUS/CHOP fusion transcripts derived from soft tissue liposarcomas.
    Schwarzbach MH; Koesters R; Germann A; Mechtersheimer G; Geisbill J; Winkler S; Niedergethmann M; Ridder R; Buechler MW; von Knebel Doeberitz M; Willeke F
    Oncogene; 2004 Sep; 23(40):6798-805. PubMed ID: 15286712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translocations, cancer and the puzzle of specificity.
    Barr FG
    Nat Genet; 1998 Jun; 19(2):121-4. PubMed ID: 9620766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tumor suppressor genes. New perspectives for clinical investigations in cancer].
    Paván J; Gualandi F; Rimessi P; Corallini A; Barbanti-Brodano G
    Medicina (B Aires); 1994; 54(2):163-8. PubMed ID: 7997135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of HOX11L2 by juxtaposition with 3'-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2).
    MacLeod RA; Nagel S; Kaufmann M; Janssen JW; Drexler HG
    Genes Chromosomes Cancer; 2003 May; 37(1):84-91. PubMed ID: 12661009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations.
    Caligiuri MA; Schichman SA; Strout MP; Mrózek K; Baer MR; Frankel SR; Barcos M; Herzig GP; Croce CM; Bloomfield CD
    Cancer Res; 1994 Jan; 54(2):370-3. PubMed ID: 8275471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription factors, translocations and haematological malignancies.
    Green AR
    Blood Rev; 1992 Jun; 6(2):118-24. PubMed ID: 1633508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gene expression in leukemia with chromosomal translocations].
    Taki T
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():109-13. PubMed ID: 17476740
    [No Abstract]   [Full Text] [Related]  

  • 40. High incidence of constitutional balanced translocations in neuroblastoma.
    Bown NP; Pearson AD; Reid MM
    Cancer Genet Cytogenet; 1993 Sep; 69(2):166-7. PubMed ID: 8402562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.